Oriola Oyj (LON:0NES)
1.180
-0.004 (-0.34%)
At close: Oct 31, 2025
Oriola Oyj Revenue
Oriola Oyj had revenue of 463.50M EUR in the quarter ending September 30, 2025, with 9.21% growth. This brings the company's revenue in the last twelve months to 1.84B, up 13.10% year-over-year. In the year 2024, Oriola Oyj had annual revenue of 1.68B with 12.45% growth.
Revenue (ttm)
1.84B EUR
Revenue Growth
+13.10%
P/S Ratio
0.12
Revenue / Employee
1.97M EUR
Employees
934
Market Cap
191.96M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.68B | 186.10M | 12.45% |
| Dec 31, 2023 | 1.50B | -44.60M | -2.90% |
| Dec 31, 2022 | 1.54B | 87.50M | 6.03% |
| Dec 31, 2021 | 1.45B | -348.70M | -19.36% |
| Dec 31, 2020 | 1.80B | 79.30M | 4.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |